• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌的甲状腺球蛋白测定、颈部超声检查及碘-131全身闪烁扫描

Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.

作者信息

Franceschi M, Kusić Z, Franceschi D, Lukinac L, Roncević S

机构信息

Department of Nuclear Medicine and Oncology, University Hospital, Sestre Milosrdnice, Zagreb, Croatia.

出版信息

J Nucl Med. 1996 Mar;37(3):446-51.

PMID:8772642
Abstract

UNLABELLED

The long-term prognosis of patients with differentiated thyroid carcinoma depends on the early diagnosis and treatment of metastases and local recurrences. We evaluated serum thyroglobulin measurements, neck ultrasonography with ultrasound-guided biopsy and 131I whole-body scintigraphy in the follow-up of 359 patients after surgical thyroidectomy and radioiodine ablation of the thyroid remnant.

METHODS

Serum thyroglobulin levels were determined and considered abnormal when the values were > 5 ng/ml. Ultrasonography over the entire neck region and fine-needle aspiration biopsy of the mass or enlarged lymph nodes were carried out using 5- and 7.5-MHz transducers and 23-gauge needles. Whole-body scintigraphy was performed after administration of 185 MBq (5 mCi)131I.

RESULTS

Increased levels of thyroglobulin (ranging from 12 to > 600 ng/ml) were measured in 40 of 55 (73%) patients with metastases or local recurrences. Ultrasonography revealed occult neck masses that were not detected by other methods. Neck ultrasonography and ultrasound-guided biopsy were positive for malignancy in 23 patients. Thyroglobulin levels were undetectable in 12 (52%) of these patients and 131I whole-body scintigraphy was negative in 19 (83%) of them.

CONCLUSION

The combined use of three diagnostic modalities (measurement of serum thyroglobulin, neck ultrasonography with ultrasound-guided biopsy for detecting recurrences of carcinoma in the neck region and 131I whole-body scintigraphy) appears to give the best results in the follows-up patients with differentiated thyroid carcinoma.

摘要

未标注

分化型甲状腺癌患者的长期预后取决于转移灶和局部复发的早期诊断与治疗。我们评估了359例甲状腺切除术后及甲状腺残余组织放射性碘消融术后患者随访过程中的血清甲状腺球蛋白测量、颈部超声检查及超声引导下活检以及131I全身显像。

方法

测定血清甲状腺球蛋白水平,当值>5 ng/ml时视为异常。使用5兆赫和7.5兆赫的换能器及23号针,对整个颈部区域进行超声检查,并对肿块或肿大淋巴结进行细针穿刺活检。给予185 MBq(5 mCi)131I后进行全身显像。

结果

55例有转移或局部复发的患者中,40例(73%)甲状腺球蛋白水平升高(范围为12至>600 ng/ml)。超声检查发现了其他方法未检测到的隐匿性颈部肿块。23例患者颈部超声检查及超声引导下活检呈恶性阳性。这些患者中有12例(52%)甲状腺球蛋白水平检测不到,19例(83%)131I全身显像为阴性。

结论

联合使用三种诊断方法(血清甲状腺球蛋白测量、颈部超声检查及超声引导下活检以检测颈部区域癌复发和131I全身显像)在分化型甲状腺癌患者的随访中似乎能取得最佳结果。

相似文献

1
Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.分化型甲状腺癌的甲状腺球蛋白测定、颈部超声检查及碘-131全身闪烁扫描
J Nucl Med. 1996 Mar;37(3):446-51.
2
Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.甲状腺球蛋白、低剂量碘-131和锝-99m-替曲膦全身闪烁扫描在分化型甲状腺癌中的应用
J Nucl Med. 1998 May;39(5):870-5.
3
Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.儿童和青少年分化型甲状腺癌:85例患者的37年经验
J Nucl Med. 1997 May;38(5):669-75.
4
Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.分化型甲状腺癌患者颈部复发的诊断
Cancer. 2003 Jan 1;97(1):90-6. doi: 10.1002/cncr.11031.
5
Comparison of thyroglobulin and radioiodine scintigraphy during follow-up of patients with differentiated thyroid carcinoma.
Eur J Med. 1992 Nov;1(7):403-6.
6
Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.甲状腺癌颈部复发:血清甲状腺球蛋白和高剂量全身扫描并非碘治疗后治愈的可靠标准。
Clin Endocrinol (Oxf). 2005 Mar;62(3):376-9. doi: 10.1111/j.1365-2265.2005.02228.x.
7
Nuclear medicine approaches in the monitoring of thyroid cancer patients.核医学方法在甲状腺癌患者监测中的应用
J BUON. 2006 Oct-Dec;11(4):511-8.
8
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.甲状腺球蛋白、放射性碘成像及正电子发射断层扫描在甲状腺癌评估中的各自作用。
Semin Nucl Med. 2006 Jul;36(3):194-205. doi: 10.1053/j.semnuclmed.2006.03.002.
9
[Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].[分化型甲状腺癌的诊断、治疗及随访]
Wien Med Wochenschr. 2005 Oct;155(19-20):429-35. doi: 10.1007/s10354-005-0219-8.
10
Baseline stimulated thyroglobulin level as a good predictor of successful ablation after adjuvant radioiodine treatment for differentiated thyroid cancers.基线刺激甲状腺球蛋白水平可作为分化型甲状腺癌辅助放射性碘治疗后成功消融的良好预测指标。
Asian Pac J Cancer Prev. 2014;15(15):6443-7. doi: 10.7314/apjcp.2014.15.15.6443.

引用本文的文献

1
Availability of Serum Levels of Carbohydrate Antigen 19-9 (CA19-9) as a Surrogate Tumor Marker for Papillary Thyroid Carcinoma.血清糖类抗原19-9(CA19-9)水平作为甲状腺乳头状癌替代肿瘤标志物的可用性。
JMA J. 2024 Apr 15;7(2):250-257. doi: 10.31662/jmaj.2023-0180. Epub 2024 Feb 9.
2
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease.甲状腺乳头状癌合并或不合并格雷夫斯病患者的比较随访研究
Diagnostics (Basel). 2022 Nov 15;12(11):2801. doi: 10.3390/diagnostics12112801.
3
The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer.
甲状腺球蛋白在分化型甲状腺癌患者术前和术后评估中的作用。
Front Endocrinol (Lausanne). 2022 Jun 2;13:872527. doi: 10.3389/fendo.2022.872527. eCollection 2022.
4
Long-Term Outcome of Differentiated Thyroid Cancer Patients-Fifty Years of Croatian Thyroid Disease Referral Centre Experience.分化型甲状腺癌患者的长期预后——克罗地亚甲状腺疾病转诊中心五十年经验
Diagnostics (Basel). 2022 Mar 30;12(4):866. doi: 10.3390/diagnostics12040866.
5
The Diagnostic Usefulness of I-SPECT/CT at Both Radioiodine Ablation and during Long-Term Follow-Up in Patients Thyroidectomized for Differentiated Thyroid Carcinoma: Analysis of Tissue Risk Factors Ascertained at Surgery and Correlated with Metastasis Appearance.I-SPECT/CT在分化型甲状腺癌甲状腺切除术后放射性碘消融及长期随访中的诊断价值:对手术确定的组织危险因素及其与转移灶出现相关性的分析
Diagnostics (Basel). 2021 Aug 20;11(8):1504. doi: 10.3390/diagnostics11081504.
6
Thyroglobulin Measurement in Needle Aspiration for Detection of Recurrences and Neck Metastases in Patients with Differentiated Thyroid Carcinoma: Significance of Anti-Tg Antibodies.甲状腺球蛋白在甲状腺癌患者细针抽吸中的检测对复发和颈部转移的意义:抗甲状腺球蛋白抗体的意义。
Acta Clin Croat. 2020 Jun;59(Suppl 1):9-17. doi: 10.20471/acc.2020.59.s1.01.
7
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a I-SPECT/CT study.长期随访分化型甲状腺癌(DTC)患者颈淋巴结转移的检测:I-SPECT/CT 研究。
BMC Cancer. 2020 Mar 20;20(1):239. doi: 10.1186/s12885-020-06744-1.
8
Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer.放射性碘难治性分化型甲状腺癌的鉴定
Chonnam Med J. 2019 Sep;55(3):127-135. doi: 10.4068/cmj.2019.55.3.127. Epub 2019 Sep 24.
9
DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131).小儿人群(≤18岁)的分化型甲状腺癌:放射性碘(I-131)术后治疗
Acta Clin Croat. 2019 Mar;58(1):119-127. doi: 10.20471/acc.2019.58.01.16.
10
THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER - CLINICAL CONSIDERATIONS.甲状腺球蛋白作为分化型甲状腺癌的肿瘤标志物——临床考量
Acta Clin Croat. 2018 Sep;57(3):518-527. doi: 10.20471/acc.2018.57.03.16.